• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Emulate, LabCorp’s Covance launch organ-on-a-chip program

October 20, 2016 By Sarah Faulkner

Emulate Inc, LabcorpEmulate, Inc. and LabCorp‘s (NYSE:LH) Covance Drug Development biz inked a deal to collaborate for an organ-on-a-chip preclinical drug evaluation and testing service.

Emulate’s organ-on-a-chip tech is designed to be a predictive model of the human body’s response to diseases and medications.

The companies plan to combine the organ modeling tech with Covance’s expertise of drug development to commercialize the organs-on-a-chip program as a platform to enhance preclinical drug development for other pharma and biotech companies.

The technology’s 1st application will be for a kidney chip, the companies reported. Researchers will evaluate how the chips can assist in drug-transporter interaction assessments, a component of preclinical testing.

The collaboration agreement allows for expansion into additional organ chips beyond the kidney chip as well as commercialization of the technology.

“We are pleased to partner with Emulate on technology that shows promise to help improve the speed and success of early-stage drug evaluation,” Covance chief scientific officer Steven Anderson said in prepared remarks. “This project is indicative of our commitment to support and implement innovative technology that can help to reduce the time, costs and risks of drug development.”

“As a leading drug development company with vast experience in drug testing standards and methodologies, Covance is the ideal partner to help accelerate the adoption of our Organs-on-Chips technology for broad application as a platform in drug development,” Emulate prez & CEO Geraldine Hamilton added. “Together, Covance and Emulate bring a combination of scientific and operational expertise to implement Organs-on-Chips as a new technology, alongside existing preclinical practices, so that we can achieve our goals of establishing improved standards, creating more predictive models, and helping to speed the development of innovative medicines.”

Filed Under: Business/Financial News, Research & Development Tagged With: Emulate Inc, LabCorp

IN CASE YOU MISSED IT

  • Abbott will spend $450M to up FreeStyle Libre production in Ireland
  • Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
  • Study backs Fluidx embolic device for vessel filling
  • Senseonics stock is up as it sticks by revenue guidance
  • Rapid Dose closes first tranche of $5M financing

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS